Company record · updated August 5, 2026
Pax Labs: 23 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs September 30, 2025 to April 30, 2026.
Source rails for this company: N-PORT fund mark (23).
Reported by 9 filers: T. Rowe Price All-Cap Opportunities Fund, T. Rowe Price All-Cap Opportunities Portfolio, T. Rowe Price Global Allocation Fund, T. Rowe Price Global Consumer Fund, T. Rowe Price Global Stock Fund, T. Rowe Price Global Technology Fund, Inc., T. Rowe Price Health Sciences Fund, Inc., T. Rowe Price Health Sciences Portfolio and 1 more.
Possibly the same company under another spelling
Filers write company names differently, and these entries differ only by a legal suffix: PAX Labs Inc. They are kept separate rather than merged, because two entities sharing a name can be genuinely different and a wrong merge would invent a history no filer reported. Check both.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2026-04-30 | price per share | 0.27 USD | T. Rowe Price Global Stock Fund | VERIFIED | valUSD 225388.44 / balance 834772.0 [class a / common / pp] | 000109926326008016 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price Global Technology Fund, Inc. | VERIFIED | valUSD 761531.12 / balance 2456552.0 [class a / common / pp] | 000109926326006613 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Portfolio | VERIFIED | valUSD 39795.32 / balance 128372.0 [class a / common / pp] | 000109926326006590 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Fund | VERIFIED | valUSD 752832.52 / balance 2428492.0 [class a / common / pp] | 000109926326006569 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 119562.04 / balance 385684.0 [class a / common / pp] | 000109926326006593 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 2603376.28 / balance 8397988.0 [class a / common / pp] | 000109926326006598 |
| 2026-03-31 | price per share | 0.31 USD | T. Rowe Price Small-Cap Value Fund, Inc. | VERIFIED | valUSD 815860.48 / balance 2631808.0 [class a / common / pp] | 000109926326006577 |
| 2026-01-31 | price per share | 0.31 USD | T. Rowe Price Global Stock Fund | VERIFIED | valUSD 258779.32 / balance 834772.0 [class a / common / pp] | 000109926326003702 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price Global Technology Fund, Inc. | VERIFIED | valUSD 761531.12 / balance 2456552.0 [class a / common / pp] | 000109926326002564 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Fund | VERIFIED | valUSD 752832.52 / balance 2428492.0 [class a / common / pp] | 000109926326002520 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Portfolio | VERIFIED | valUSD 39795.32 / balance 128372.0 [class a / common / pp] | 000109926326002541 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 119562.04 / balance 385684.0 [class a / common / pp] | 000109926326002544 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 2603376.28 / balance 8397988.0 [class a / common / pp] | 000109926326002549 |
| 2025-12-31 | price per share | 0.31 USD | T. Rowe Price Small-Cap Value Fund, Inc. | VERIFIED | valUSD 815860.48 / balance 2631808.0 [class a / common / pp] | 000109926326002528 |
| 2025-10-31 | price per share | 0.31 USD | T. Rowe Price Global Stock Fund | VERIFIED | valUSD 258779.32 / balance 834772.0 [class a / common / pp] | 000109926325005046 |
| 2025-10-31 | price per share | 0.31 USD | T. Rowe Price Global Allocation Fund | VERIFIED | valUSD 6687.32 / balance 21572.0 [class a / common / pp] | 000109926325005062 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price Global Technology Fund, Inc. | VERIFIED | valUSD 761531.12 / balance 2456552.0 [class a / common / pp] | 000109926325003657 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Portfolio | VERIFIED | valUSD 39795.32 / balance 128372.0 [class a / common / pp] | 000109926325003634 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price All-Cap Opportunities Fund | VERIFIED | valUSD 752832.52 / balance 2428492.0 [class a / common / pp] | 000109926325003613 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price Global Consumer Fund | VERIFIED | valUSD 7922.36 / balance 25556.0 [class a / common / pp] | 000109926325003610 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price Health Sciences Fund, Inc. | VERIFIED | valUSD 2603376.28 / balance 8397988.0 [class a / common / pp] | 000109926325003642 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price Health Sciences Portfolio | VERIFIED | valUSD 119562.04 / balance 385684.0 [class a / common / pp] | 000109926325003637 |
| 2025-09-30 | price per share | 0.31 USD | T. Rowe Price Small-Cap Value Fund, Inc. | VERIFIED | valUSD 815860.48 / balance 2631808.0 [class a / common / pp] | 000109926325003621 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.